These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15078096)

  • 1. Enhancement of the inhibitory activity of oatp antisense oligonucleotides by incorporation of 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) without a loss of subtype selectivity.
    Takagi M; Morita K; Nakai D; Nakagomi R; Tokui T; Koizumi M
    Biochemistry; 2004 Apr; 43(15):4501-10. PubMed ID: 15078096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of oatp subtype-specific antisense oligonucleotides having 2'-O,4'-C-ethylene-bridged nucleic acids (ENA).
    Takagi M; Morita K; Nakai D; Nakagomi R; Tokui T; Koizumi M
    Nucleic Acids Res Suppl; 2003; (3):83-4. PubMed ID: 14510391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) as next-generation antisense and antigene agents.
    Koizumi M
    Biol Pharm Bull; 2004 Apr; 27(4):453-6. PubMed ID: 15056846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver.
    Vavricka SR; Van Montfoort J; Ha HR; Meier PJ; Fattinger K
    Hepatology; 2002 Jul; 36(1):164-72. PubMed ID: 12085361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and properties of 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) as effective antisense oligonucleotides.
    Morita K; Takagi M; Hasegawa C; Kaneko M; Tsutsumi S; Sone J; Ishikawa T; Imanishi T; Koizumi M
    Bioorg Med Chem; 2003 May; 11(10):2211-26. PubMed ID: 12713831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of antisense oligonucleotides on the expression of hepatocellular bile acid and organic anion uptake systems in Xenopus laevis oocytes.
    Hagenbuch B; Scharschmidt BF; Meier PJ
    Biochem J; 1996 Jun; 316 ( Pt 3)(Pt 3):901-4. PubMed ID: 8670169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2'-O,4'-C-ethylene-bridged nucleic acids (ENA): highly nuclease-resistant and thermodynamically stable oligonucleotides for antisense drug.
    Morita K; Hasegawa C; Kaneko M; Tsutsumi S; Sone J; Ishikawa T; Imanishi T; Koizumi M
    Bioorg Med Chem Lett; 2002 Jan; 12(1):73-6. PubMed ID: 11738576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ENA oligonucleotides as therapeutics.
    Koizumi M
    Curr Opin Mol Ther; 2006 Apr; 8(2):144-9. PubMed ID: 16610767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) with nuclease-resistance and high affinity for RNA.
    Morita K; Hasegawa C; Kaneko M; Tsutsumi S; Sone J; Ishikawa T; Imanishi T; Koizumi M
    Nucleic Acids Res Suppl; 2001; (1):241-2. PubMed ID: 12836354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of VEGF mRNA by 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) antisense oligonucleotides and their influence on off-target gene expressions.
    Morita K; Yamate K; Kurakata S; Abe K; Watanabe K; Koizumi M; Imanishi T
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(4-6):503-21. PubMed ID: 16838842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformationally constrained 2'-N,4'-C-ethylene-bridged thymidine (aza-ENA-T): synthesis, structure, physical, and biochemical studies of aza-ENA-T-modified oligonucleotides.
    Varghese OP; Barman J; Pathmasiri W; Plashkevych O; Honcharenko D; Chattopadhyaya J
    J Am Chem Soc; 2006 Nov; 128(47):15173-87. PubMed ID: 17117869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine tuning of electrostatics around the internucleotidic phosphate through incorporation of modified 2',4'-carbocyclic-LNAs and -ENAs leads to significant modulation of antisense properties.
    Zhou C; Liu Y; Andaloussi M; Badgujar N; Plashkevych O; Chattopadhyaya J
    J Org Chem; 2009 Jan; 74(1):118-34. PubMed ID: 19055352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the RNase H cleavage kinetics and blood serum stability of the north-conformationally constrained and 2'-alkoxy modified oligonucleotides.
    Honcharenko D; Barman J; Varghese OP; Chattopadhyaya J
    Biochemistry; 2007 May; 46(19):5635-46. PubMed ID: 17411072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The organic anion transport polypeptide 1d1 (Oatp1d1) mediates hepatocellular uptake of phalloidin and microcystin into skate liver.
    Meier-Abt F; Hammann-Hänni A; Stieger B; Ballatori N; Boyer JL
    Toxicol Appl Pharmacol; 2007 Feb; 218(3):274-9. PubMed ID: 17198718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Edoxaban transport via P-glycoprotein is a key factor for the drug's disposition.
    Mikkaichi T; Yoshigae Y; Masumoto H; Imaoka T; Rozehnal V; Fischer T; Okudaira N; Izumi T
    Drug Metab Dispos; 2014 Apr; 42(4):520-8. PubMed ID: 24459178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of OATP-, NTCP- and OCT-mediated substrate uptake activities in individual and pooled batches of cryopreserved human hepatocytes.
    De Bruyn T; Ye ZW; Peeters A; Sahi J; Baes M; Augustijns PF; Annaert PP
    Eur J Pharm Sci; 2011 Jul; 43(4):297-307. PubMed ID: 21605667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine-tuning of ENA gapmers as antisense oligonucleotides for sequence-specific inhibition.
    Takagi-Sato M; Tokuhiro S; Kawaida R; Koizumi M
    Oligonucleotides; 2007; 17(3):291-301. PubMed ID: 17854269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and species similarity of OATP transporters responsible for hepatic uptake of beta-lactam antibiotics.
    Nakakariya M; Shimada T; Irokawa M; Maeda T; Tamai I
    Drug Metab Pharmacokinet; 2008; 23(5):347-55. PubMed ID: 18974612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of rat organic anion transporters in bile salt-induced cholestatic hepatitis: effect of ursodeoxycholate.
    Rost D; Herrmann T; Sauer P; Schmidts HL; Stieger B; Meier PJ; Stremmel W; Stiehl A
    Hepatology; 2003 Jul; 38(1):187-95. PubMed ID: 12830001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organic anion-transporting polypeptides contribute to the hepatic uptake of berberine.
    Chen C; Wu ZT; Ma LL; Ni X; Lin YF; Wang L; Chen KP; Huang CG; Pan G
    Xenobiotica; 2015; 45(12):1138-46. PubMed ID: 26068524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.